[1]Zhang R, Meng J, Wang X, et al. Metabolomics of ischemic stroke: insights into risk prediction and mechanisms[J]. Metab Brain Dis, 2022, 37(7): 2163-2180.
[2]De Meyer SF, Langhauser F, Haupeltshofer S, et al. Thromboinflammation in brain ischemia: recent updates and future perspectives[J]. Stroke, 2022, 53(5): 1487-1499.
[3]Kapanova G, Tashenova G, Akhenbekova A, et al. Cerebral ischemia reperfusion injury: from public health perspectives to mechanisms[J]. Folia Neuropathol, 2022, 60(4): 384-389.
[4]Xu Y, Liu Y, Li K, et al. Regulation of PGE2 pathway during cerebral ischemia reperfusion injury in rat[J]. Cell Mol Neurobiol, 2021, 41(7): 1483-1496.
[5]Wu X, Peng K, Huang H, et al. MiR-21b-3p protects NS2OY cells against oxygen-glucose deprivation/reperfusion-induced injury by down-regulating cyclooxygenase-2[J]. Am J Transl Res, 2019, 11(5): 3007-3017.
[6]Zhang L, Sui S, Wang S, et al. Neuroprotective effect of corosolic acid against cerebral ischemia-reperfusion injury in experimental rats[J]. Oleo Sci, 2022, 71(10):1501-1510.
[7]Evzelman MA, Mityaeva EV, Lashkhiia IB, et al. Acute cerebral ischemia and inflammation[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2019, 119(12. Vyp. 2): 73-80.
[8]Cui J, Jia J. Natural COX-2 Inhibitors as promising anti-inflammatory agents: an update[J]. Curr Med Chem, 2021, 28(18): 3622-3646.
[9]Cheng M, Liang X,Shi L, et al. Folic acid deficiency exacerbates the inflammatory response of astrocytes after ischemia0-reperfusion by enhancing the interaction between IL-6 and JAK-1/pSTAT3[J]. CNS Neurosci Ther, 2023, 29(6): 1537-1546.
[10]Zhang P, Cui J. Neuroprotective effect of fisetin against the cerebral ischemia-reperfusion damage via suppression of oxidative stress and inflammatory parameters[J]. Inflammation, 2021, 44(4): 1490-1506.
[11]Li T, Zhang W, Hu E, et al. Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury[J]. Comput Struct Biotechnol J, 2021, 26(19): 1002-1013.
[12]Shi K, Tian DC, Li ZG, et al. Global brain inflammation in stroke[J]. Lancet Neurol, 2019, 18(11): 1058-1066.
[13]Mo ZT, Zheng J, Liao YL. Icariin inhibits the expression of IL-1β, IL-6 and TNF-α induced by OGD/R through the IRE1/XBP1s pathway in microglia[J]. Pharm Biol, 2021, 59(1): 1473-1479.
[14]Hu E, Li T, Li Z, et al. Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury et al[J]. Pharm Biol, 2023, 61(1): 1054-1064.
[15]Cruz JV, Rosa JMC, Kimani NM, et al. The role of celecoxib as a potential inhibitor in the treatment of inflammatory diseases - a review[J]. Curr Med Chem, 2022, 29(17): 3028-3049.
[16]Longa EZ, MD, Weinstein PR, Carlson S,et al. Reversible middle cerebral artery occlusion without caraniectomy in rats[J]. Stroke, 1989, 20(1): 84-91.
[17]Shabani M, Erfani S, Abdolmaleki A, et al. Alpha-pinene modulates inflammatory response and protects against brain ischemia via inducible nitric oxide synthase-nuclear factor-kappa B-cyclooxygenase-2 pathway[J]. Mol Biol Rep, 2023, 50(8): 6505-6516.
[18]Liu J, Zhou Y, Xie C, et al. Anti-ferroptotic effects of bone marrow mesenchymal stem cell-derived extracellular vesicles loaded with ferrostatin-1 in cerebral ischemia-reperfusion injury associate with the GPX4/COX-2 axis[J]. Neurochem Res, 2023, 48(2): 502-518.
[19]Yan Y, Tong F, Chen J. Endogenous BMP-4/ROS/COX-2 mediated IPC and resveratrol alleviated brain damage[J]. Curr Pharm Des, 2019, 25(9): 1030-1039.
[20]Xu Y, Liu Y, Li K, et al. COX-2/PGE2 pathway inhibits the ferroptosis induced by cerebral ischemia reperfusion[J]. Mol Neurobiol, 2022, 59(3): 1619-1631.
[21]Jiang J, Yu Y. Small molecules targeting cyclooxygenase/prostanoid cascade in experimental brain ischemia: Do they translate[J]. Med Res Rev, 2021, 41(2): 828-857.
[22]Kim HK, Lee JJ, Choi G, et al. Gadolinium-based neuroprognostic magnetic resonance imaging agents suppress cox-2 for prevention of reperfusion injury after stroke[J]. J Med Chem, 2020, 63(13): 6909-6923.
[23]Purroy F, Farré-Rodriguez J, Mauri-Capdevila G, et al. Basal IL-6 and S100b levels are associated with infarct volume[J]. Acta Neurol Scand, 2021, 144(5): 517-523.
[24]Kao MH, Wu JS, Cheung WM, et al. Clinacanthus nutans mitigates neuronal death and reduces ischemic brain injury: role of NF-κB-driven IL-1β transcription[J]. Neuromolecular Med, 2021, 23(1): 199-210.
[25]Wei J, Zhang J, Wang D, et al. The COX-2-PGE2 pathway promotes tumor evasion in colorectal adenomas[J]. Cancer Prev Res, 2022, 15(5): 285-296.
[26]Szlasa W, Slusarczyk S, Nawrot-Hadzik I, et al. Betulin and its derivatives reduce inflammation and COX-2 activity in macrophages[J]. Inflammation, 2023, 46(2): 573-583.
[27]Gao P, Rao ZW, Li M, et al. Tetrandrine represses inflammation and attenuates osteoarthritis by selective inhibition of COX-2[J]. Curr Med Sci, 2023, 43(3): 505-513.
[28]Adamstein NH, Cornel JH, Davidson M, et al. Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the rescue clinical trial[J]. JAMA Cardiol, 2023, 8(2): 177-181.
|